The $425 central target is calculated from 11 individual analyst price targets that can be attributed to specific firms, with a low of $350 and a high of $500. That is a notably wide spread of $150, reflecting how differently the Street weighs the company's growth against its regulatory and credit exposure. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent post-earnings revisions illustrate the split. After third-quarter results, DAVE saw several firms trim targets: UBS lowered its target to $450, Canaccord Genuity held at $450, Keefe Bruyette cut to $380 from $435, and JPMorgan reduced its target to $435 from $480. On the cautious side, Evercore ISI and Monness Crespi both sit at $350. Yet other firms moved higher, with Lake Street raising its target to $480 and Loop Capital maintaining the Street-high $500. In between, B. Riley set $449, Piper Sandler $390, and Seaport Research $422.
The aggregate view remains a "Buy" consensus with no sell ratings, but the dispersion between $350 and $500 shows analysts disagree sharply on whether regulatory risk and credit costs will compress the valuation or whether strong growth and profitability will drive the shares back toward prior highs.
With the stock recently trading near $282.65, reaching $425 implies upside of roughly 50% — a substantial move. Dave's market capitalization is about $3.6 billion, and the shares trade at a trailing P/E of roughly 20, with a forward P/E near 15.
Fundamentals remain strong on the top line. In its latest quarter, revenue rose 31% year over year to about $198 million, adjusted EBITDA climbed 39% to $82 million, and the company raised full-year 2026 guidance to revenue of $746 million to $750 million and adjusted EBITDA of $327 million to $330 million. The challenge is that the stock fell roughly 18% after earnings, because adjusted EPS came in below consensus, credit-loss provisions exceeded forecasts, and the company disclosed regulatory subpoenas.
Several factors could underpin a path toward the $425 target. Revenue growth of roughly 31% and record member additions demonstrate durable demand for ExtraCash, Dave's small-dollar cash-advance product. Management also lifted guidance, signaling confidence in near-term momentum. The company's profitability profile — a roughly 40% adjusted EBITDA margin and positive free cash flow — supports a reasonable valuation case, especially with a forward P/E near 15.
Capital-return actions add support: Dave has an upsized $300 million buyback authorization and added liquidity, which can both signal management confidence and reduce share count. A consensus "Buy" rating, with no sell ratings across tracked analysts, reflects generally favorable sentiment, even if individual targets vary widely.
The principal obstacle is regulatory risk. Dave disclosed subpoenas and inquiries from government departments in Connecticut, Maryland, and New York, including the New York State Department of Financial Services and the New York attorney general, and it continues to contest a Department of Justice lawsuit. These are inquiries rather than findings, but they land on a business model built around fee and tip monetization of cash advances.
Credit risk is a second concern. ExtraCash originations rose 23% to $2.5 billion, and the provision for credit losses reached $37 million, above management's own forecast. Faster growth in lending necessarily carries higher potential losses, and the company's non-GAAP gross margin slipped from 72% to 70% sequentially. If monetization and credit losses move together, profit growth could lag revenue growth, pressuring the valuation. The stock's high beta of about 4.0 also means sharp swings can work against shareholders.
The shares remain roughly 39% below their 52-week high of $458.25, which now stands as a major resistance level on any recovery toward $425. The 52-week low of $152.21 marks the floor established earlier in the year. The $300 level is a notable psychological threshold, and the $350 area — where several analysts cluster targets — could serve as an intermediate resistance zone. A sustained move above $350 would signal buyers are reasserting control, while failure to hold gains above $300 could keep the stock range-bound.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms use their own valuation frameworks and timeframes. Investors should watch upcoming earnings and guidance updates, any changes to analyst targets or ratings, and further developments in the regulatory inquiries and the Department of Justice matter. Credit metrics such as the provision for credit losses, delinquency trends, and gross margins will be critical, as will broader fintech sector sentiment and interest-rate conditions that affect funding costs.
The $425 central target, derived from roughly 11 analyst targets ranging from $350 to $500, implies a substantial gain of about 50% from the recent price near $282.65. Support comes from accelerating revenue, raised guidance, solid profitability, and an upsized buyback. The principal obstacles are regulatory scrutiny and rising credit costs, which explain why analyst views diverge so widely. Whether Dave can reach $425 will depend on how it balances growth with credit discipline and resolves the regulatory questions. Investors should monitor earnings, credit metrics, and regulatory developments before drawing any conclusions.
In my own research, I frequently turn to Tickeron’s AI Daily Buy/Sell Signals to monitor stocks like DAVE. These AI-generated signals help track shifting technical conditions and market trends in real time, providing an additional layer alongside fundamental analysis and analyst targets. This approach has helped me stay objective when evaluating opportunities in volatile names.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a +2.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where DAVE advanced for three days, in 281 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
DAVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 209 of 222 cases where DAVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DAVE as a result. In 66 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for DAVE turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 38 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
DAVE moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for DAVE crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DAVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Tickeron SMR rating for this company is 13 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. DAVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.093) is normal, around the industry mean (-1.906). P/E Ratio (16.652) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.050) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (8.104) is also within normal values, averaging (70.383).
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DAVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of barbeque restaurants
Industry PackagedSoftware